» Articles » PMID: 23308199

Reduced RAN Expression and Disrupted Transport Between Cytoplasm and Nucleus; a Key Event in Alzheimer's Disease Pathophysiology

Overview
Journal PLoS One
Date 2013 Jan 12
PMID 23308199
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Transcription of DNA is essential for cell maintenance and survival; inappropriate localization of proteins that are involved in transcription would be catastrophic. In Alzheimer's disease brains, and in vitro studies, we have found qualitative and quantitative deficits in transport into the nucleus of DNA methyltransferase 1 (DNMT1) and RNA polymerase II (RNA pol II), accompanied by their abnormal sequestration in the cytoplasm. RAN (RAs-related Nuclear protein) knockdown, by siRNA and oligomeric Aβ42 treatment in neurons, replicate human data which indicate that transport disruption in AD may be mechanistically linked to reduced expression of RAN, a pivotal molecule in nucleocytoplasmic transport. In vitro studies also indicate a significant role for oligomeric Aβ42 in the observed phenomena. We propose a model in which reduced transcription regulators in the nucleus and their increased presence in the cytoplasm may lead to many of the cellular manifestations of Alzheimer's disease.

Citing Articles

Massive changes in gene expression and their cause(s) can be a unifying principle in the pathobiology of Alzheimer's disease.

Coleman P, Delvaux E, Kordower J, Boehringer A, Huseby C Alzheimers Dement. 2025; 21(2):e14555.

PMID: 39912452 PMC: 11851168. DOI: 10.1002/alz.14555.


Alzheimer's disease-associated CD83(+) microglia are linked with increased immunoglobulin G4 and human cytomegalovirus in the gut, vagal nerve, and brain.

Readhead B, Mastroeni D, Wang Q, Sierra M, de Avila C, Jimoh T Alzheimers Dement. 2024; 21(1):e14401.

PMID: 39698934 PMC: 11772737. DOI: 10.1002/alz.14401.


MicroRNA biogenesis pathway alterations in aging.

Sanz-Ros J, Mas-Bargues C, Romero-Garcia N, Huete-Acevedo J, Dromant M, Borras C Extracell Vesicles Circ Nucl Acids. 2024; 4(3):486-501.

PMID: 39698023 PMC: 11648461. DOI: 10.20517/evcna.2023.29.


Primate-specific 82-kDa choline acetyltransferase attenuates progression of Alzheimer's disease-like pathology in the APP knock-in mouse model.

AlQot H, Rylett R Sci Rep. 2024; 14(1):27614.

PMID: 39528509 PMC: 11555257. DOI: 10.1038/s41598-024-78751-2.


Neuropathological mRNA Expression Changes after Single Mild Traumatic Brain Injury in Pigs.

Grovola M, Cullen D Biomedicines. 2024; 12(9).

PMID: 39335533 PMC: 11428889. DOI: 10.3390/biomedicines12092019.


References
1.
Robertson K, Ait-Si-Ali S, Yokochi T, Wade P, Jones P, Wolffe A . DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat Genet. 2000; 25(3):338-42. DOI: 10.1038/77124. View

2.
Barres V, Ouellet V, Lafontaine J, Tonin P, Provencher D, Mes-Masson A . An essential role for Ran GTPase in epithelial ovarian cancer cell survival. Mol Cancer. 2010; 9:272. PMC: 2964620. DOI: 10.1186/1476-4598-9-272. View

3.
Carre C, Shiekhattar R . Human GTPases associate with RNA polymerase II to mediate its nuclear import. Mol Cell Biol. 2011; 31(19):3953-62. PMC: 3187354. DOI: 10.1128/MCB.05442-11. View

4.
Husseman J, Hallows J, Bregman D, Leverenz J, Nochlin D, Jin L . Hyperphosphorylation of RNA polymerase II and reduced neuronal RNA levels precede neurofibrillary tangles in Alzheimer disease. J Neuropathol Exp Neurol. 2002; 60(12):1219-32. DOI: 10.1093/jnen/60.12.1219. View

5.
Liang W, Dunckley T, Beach T, Grover A, Mastroeni D, Ramsey K . Neuronal gene expression in non-demented individuals with intermediate Alzheimer's Disease neuropathology. Neurobiol Aging. 2008; 31(4):549-66. PMC: 2844804. DOI: 10.1016/j.neurobiolaging.2008.05.013. View